Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP543853.RAqFpJWrOEwN5d70gLKkprIhdo1MYGGGkQPgXF2gD_-RA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP543853.RAqFpJWrOEwN5d70gLKkprIhdo1MYGGGkQPgXF2gD_-RA130_assertion type Assertion NP543853.RAqFpJWrOEwN5d70gLKkprIhdo1MYGGGkQPgXF2gD_-RA130_head.
- NP543853.RAqFpJWrOEwN5d70gLKkprIhdo1MYGGGkQPgXF2gD_-RA130_assertion description "[The findings of the current study suggest that adenocarcinoma cases with CIMP have a poorer prognosis than adenocarcinoma cases without CIMP, and the EGFR mutation was shown to have an inverse correlation with methylation of SPARC and the p16INK4A gene in NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP543853.RAqFpJWrOEwN5d70gLKkprIhdo1MYGGGkQPgXF2gD_-RA130_provenance.
- NP543853.RAqFpJWrOEwN5d70gLKkprIhdo1MYGGGkQPgXF2gD_-RA130_assertion evidence source_evidence_literature NP543853.RAqFpJWrOEwN5d70gLKkprIhdo1MYGGGkQPgXF2gD_-RA130_provenance.
- NP543853.RAqFpJWrOEwN5d70gLKkprIhdo1MYGGGkQPgXF2gD_-RA130_assertion SIO_000772 16598760 NP543853.RAqFpJWrOEwN5d70gLKkprIhdo1MYGGGkQPgXF2gD_-RA130_provenance.
- NP543853.RAqFpJWrOEwN5d70gLKkprIhdo1MYGGGkQPgXF2gD_-RA130_assertion wasDerivedFrom befree-2016 NP543853.RAqFpJWrOEwN5d70gLKkprIhdo1MYGGGkQPgXF2gD_-RA130_provenance.
- NP543853.RAqFpJWrOEwN5d70gLKkprIhdo1MYGGGkQPgXF2gD_-RA130_assertion wasGeneratedBy ECO_0000203 NP543853.RAqFpJWrOEwN5d70gLKkprIhdo1MYGGGkQPgXF2gD_-RA130_provenance.